A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 22
Summary
- Conditions
- Colorectal Neoplasms
- Solid Neoplasms
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Description
The study will be conducted in 2 parts: dose escalation part and expansion part. The study will include Pre-treatment Phase, Treatment Phase, and Extension Phase (in expansion part only). Eligible participants from Pre-Treatment Phase (screening period) will enter into the Treatment Phase to receive...
The study will be conducted in 2 parts: dose escalation part and expansion part. The study will include Pre-treatment Phase, Treatment Phase, and Extension Phase (in expansion part only). Eligible participants from Pre-Treatment Phase (screening period) will enter into the Treatment Phase to receive E7386. After Treatment Phase, participants will be followed in follow-up period of Extension Phase (in expansion part only).
Tracking Information
- NCT #
- NCT03833700
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon